American Eagle Outfitters stock price target raised to $14 from $9 at Barclays

American Eagle Outfitters (AEO) is seeing increased analyst price targets following a strong Q2 FY25 earnings beat, with EPS of $0.45 against a $0.20 forecast and revenue of $1.28 billion surpassing $1.23 billion. Barclays raised its price target to $14.00 from $9.00, citing gross margin expansion, stronger traffic, and improved near-term visibility, notably maintaining an Underweight rating despite significant upward adjustments to its EPS estimates for FY25-FY27. Concurrently, UBS increased its price target to $21.50 from $19.00, reiterating a Buy rating, driven by the growth potential of the Aerie segment. These revisions highlight AEO's robust operational performance and a nuanced but generally positive outlook from the analyst community.

Analysis

American Eagle Outfitters (AEO) demonstrated significant operational outperformance in its second-quarter fiscal 2025 results, posting an earnings per share of $0.45, more than double the $0.20 forecast, on revenue of $1.28 billion which surpassed the $1.23 billion estimate. This strength is attributed to a notable gross margin expansion to 36.9%, driven by reduced promotional activity, alongside improved store traffic and conversion rates. The positive results have triggered divergent but directionally positive revisions from Wall Street. Barclays raised its price target to $14.00 from $9.00, citing the earnings beat and improved near-term visibility. This new target is based on an increased 9x P/E multiple applied to a raised fiscal 2027 EPS estimate of $1.61. However, Barclays maintains its 'Underweight' rating, indicating that despite the strong execution, concerns may persist regarding the stock's valuation or long-term competitive positioning. In contrast, UBS holds a more bullish view, raising its price target to $21.50 from $19.00 and reiterating a 'Buy' rating, specifically highlighting the growth potential within the Aerie segment. The company's consistent dividend payments for 22 consecutive years and upward earnings revisions from five analysts further underscore its current fundamental health and positive momentum.

Key Decisions for Investors

• Investors should weigh the strong operational momentum and significant earnings beat against the divergent analyst ratings, particularly noting that Barclays' 'Underweight' rating persists despite a substantial price target increase.
• Monitor gross margin trends and the performance of the Aerie segment, as continued margin strength without heavy promotions and growth in Aerie are the key catalysts cited by analysts.
• Consider the valuation discrepancy, as Barclays' 9x multiple on FY27 earnings for a $14 price target contrasts with UBS's more bullish 'Buy' rating and $21.50 target, suggesting the market is still debating the appropriate long-term valuation for the stock.